Data_Sheet_2_Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan.xlsx by Bo Jin (169366)

“…<p>There has been a decreasing trend in new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases and fatalities worldwide. …”

Data_Sheet_1_Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan.xlsx by Bo Jin (169366)

“…<p>There has been a decreasing trend in new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases and fatalities worldwide. …”

Nanobody 19 stabilizes PRL-3 structure at two sites and destabilizes PRL-3 at one interaction point. by Caroline N. Smith (15852909)

Nanobody 26 stabilizes PRL-3 structure at two sites and destabilizes PRL-3 at one interaction point. by Caroline N. Smith (15852909)

PCNA-I1 reversibly blocks HSV-1 DNA replication. by Jessica E. Packard (16641690)

siRNA silencing of PhLP3 promotes MAPK phosphorylation upstream of RhoA activation and PhLP3 overexpression decreases levels of phosphorylated MAPK in suspension CHO LB01 cells. by Nandini V. L. Hayes (192607)

Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital h... by X.W. Li (6546986)

Plant and Animal Species Activity in a Forest Setting by Patricia Agustin (3115977)

“…All of these categories will increase/decrease in number in a particular setting. In the case of the Saywell Forest, there will be a decrease of ground cover will occur in the forest setting.…”

Serum IgM samples by COVID-19 disease severity (mild, moderate, severe) binding to the various SARS-CoV-2 protein antigens compared to no disease (NC). by Marie Le Berre (6299012)

Serum IgG samples by COVID-19 disease severity (mild, moderate, severe) binding to the various SARS-CoV-2 protein antigens compared to no disease (NC). by Marie Le Berre (6299012)

EFFECT OF STEEL PLATE THICKNESSES AND FLUID FLOW CHARACTERISTICS OF AN IMPINGING AIR JET ON HEAT TRANSFER AT THE STAGNATION POINT by K. Jeyajothi (7032425)

Consequences of global and local c-di-GMP changes on <i>V</i>. by Andrew A. Bridges (1587328)

“…<p><b><i>cholerae</i> gene expression patterns.</b> Bottom panel: mean global c-di-GMP reporter outputs for the indicated strains and conditions expressed as percentage differences relative to untreated wild-type <i>V</i>. …”

Overlapping end points of ice sublimation and desorption drying as detected by temperature probes and Pirani gauge pressure measurements by Geoff Smith (6064268)

Structural Basis for Sequence Specific DNA Binding and Protein Dimerization of HOXA13 by Yonghong Zhang (20918)

“…I366 makes similar methyl contacts with T3* and T4*. Mutants (I366A, N370A and V373G) all have decreased DNA binding and transcriptional activity. …”

<i>Cotton Leaf Curl Multan virus</i> C4 protein suppresses both transcriptional and post-transcriptional gene silencing by interacting with SAM synthetase by Asigul Ismayil (5698946)

“…Plants infected with CLCuMuV carrying C4^R13A show decreased levels of symptoms and viral DNA accumulation associated with enhanced viral DNA methylation. …”

The scatterplot, linear regression equation, 95% confidence band, and <i>p</i>-value for the concentration of arsenic (As) in micrograms per liter (μg/L) versus oxidation-reduction... by Seth H. Frisbie (7821866)

Maternal Clinical Diagnoses and Hospital Variation in the Risk of Cesarean Delivery: Analyses of a National US Hospital Discharge Database by Katy B. Kozhimannil (614638)

Lipid droplets transiently increase in size during early stages of HSV-1 infection. by Kamal L. Nahas (13014698)

Data_Sheet_1_METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.docx by Jian Wang (5901)

“…Levels of m⁶A are decreased after colistin treatment in mRTECs. …”

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”